Home

másrészről, Reggel oldal mhc molecules manczinger mate vászon szelet Indulás

MHC II immunogenicity shapes the neoepitope landscape in human tumors |  Nature Genetics
MHC II immunogenicity shapes the neoepitope landscape in human tumors | Nature Genetics

Peptide presentation by HLA-DQ molecules is associated with the development  of immune tolerance [PeerJ]
Peptide presentation by HLA-DQ molecules is associated with the development of immune tolerance [PeerJ]

Self-mediated positive selection of T cells sets an obstacle to the  recognition of nonself | PNAS
Self-mediated positive selection of T cells sets an obstacle to the recognition of nonself | PNAS

Máté MANCZINGER | Principal Investigator | PhD | Biological Research  Centre, Hungarian Academy of Sciences, Szeged | BRC | Institute of  Biochemistry | Research profile
Máté MANCZINGER | Principal Investigator | PhD | Biological Research Centre, Hungarian Academy of Sciences, Szeged | BRC | Institute of Biochemistry | Research profile

Proto-oncogene PML controls genes devoted to MHC class I antigen  presentation | Nature
Proto-oncogene PML controls genes devoted to MHC class I antigen presentation | Nature

Differences In MHC Molecules In Regions With High Pathogen Diversity -  Science Trends
Differences In MHC Molecules In Regions With High Pathogen Diversity - Science Trends

Pathogen diversity drives the evolution of generalist MHC-II alleles in  human populations | PLOS Biology
Pathogen diversity drives the evolution of generalist MHC-II alleles in human populations | PLOS Biology

Major histocompatibility complex - Wikipedia
Major histocompatibility complex - Wikipedia

Pathogen diversity drives the evolution of generalist MHC-II alleles in  human populations – Immunoinfo
Pathogen diversity drives the evolution of generalist MHC-II alleles in human populations – Immunoinfo

Mate Manczinger (@matemanc) / Twitter
Mate Manczinger (@matemanc) / Twitter

Advances in the Evolutionary Understanding of MHC Polymorphism: Trends in  Genetics
Advances in the Evolutionary Understanding of MHC Polymorphism: Trends in Genetics

Pathogen diversity drives the evolution of promiscuous peptide binding of  human MHC-II alleles | bioRxiv
Pathogen diversity drives the evolution of promiscuous peptide binding of human MHC-II alleles | bioRxiv

Sex-and age-specific MHC presentation of observed driver mutations in... |  Download Scientific Diagram
Sex-and age-specific MHC presentation of observed driver mutations in... | Download Scientific Diagram

Mutant MHC class II epitopes drive therapeutic immune responses to cancer |  Nature
Mutant MHC class II epitopes drive therapeutic immune responses to cancer | Nature

Mate Manczinger (@matemanc) / Twitter
Mate Manczinger (@matemanc) / Twitter

Cells | Free Full-Text | Avian MHC Evolution in the Era of Genomics: Phase  1.0
Cells | Free Full-Text | Avian MHC Evolution in the Era of Genomics: Phase 1.0

Negative trade-off between neoantigen repertoire breadth and the  specificity of HLA-I molecules shapes antitumor immunity | Nature Cancer
Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumor immunity | Nature Cancer

Major histocompatibility complex - Wikipedia
Major histocompatibility complex - Wikipedia

Advances in the Evolutionary Understanding of MHC Polymorphism -  ScienceDirect
Advances in the Evolutionary Understanding of MHC Polymorphism - ScienceDirect

Mate Manczinger (@matemanc) / Twitter
Mate Manczinger (@matemanc) / Twitter

Mate Manczinger (@matemanc) / Twitter
Mate Manczinger (@matemanc) / Twitter

PDF) Negative trade-off between neoantigen repertoire breadth and the  specificity of HLA-I molecules shapes antitumor immunity
PDF) Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumor immunity

Frontiers | From Chickens to Humans: The Importance of Peptide Repertoires  for MHC Class I Alleles
Frontiers | From Chickens to Humans: The Importance of Peptide Repertoires for MHC Class I Alleles

Negative trade-off between neoantigen repertoire breadth and the  specificity of HLA-I molecules shapes antitumour immunity | bioRxiv
Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumour immunity | bioRxiv

Reversion analysis reveals the in vivo immunogenicity of a poorly MHC  I-binding cancer neoepitope | Nature Communications
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope | Nature Communications

Major histocompatibility complex - Wikipedia
Major histocompatibility complex - Wikipedia